193 related articles for article (PubMed ID: 21724844)
1. The Mef2A transcription factor coordinately regulates a costamere gene program in cardiac muscle.
Ewen EP; Snyder CM; Wilson M; Desjardins D; Naya FJ
J Biol Chem; 2011 Aug; 286(34):29644-53. PubMed ID: 21724844
[TBL] [Abstract][Full Text] [Related]
2. Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein.
Durham JT; Brand OM; Arnold M; Reynolds JG; Muthukumar L; Weiler H; Richardson JA; Naya FJ
J Biol Chem; 2006 Mar; 281(10):6841-9. PubMed ID: 16407236
[TBL] [Abstract][Full Text] [Related]
3. Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting protein.
Huang HT; Brand OM; Mathew M; Ignatiou C; Ewen EP; McCalmon SA; Naya FJ
J Biol Chem; 2006 Dec; 281(51):39370-9. PubMed ID: 17046827
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.
Wang YX; Qian LX; Liu D; Yao LL; Jiang Q; Yu Z; Gui YH; Zhong TP; Song HY
Cardiovasc Res; 2007 May; 74(2):290-303. PubMed ID: 17367767
[TBL] [Abstract][Full Text] [Related]
5. Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons.
Yamada T; Yang Y; Huang J; Coppola G; Geschwind DH; Bonni A
J Neurosci; 2013 Mar; 33(11):4726-40. PubMed ID: 23486945
[TBL] [Abstract][Full Text] [Related]
6. Identification of HZF1 as a novel target gene of the MEF2 transcription factor.
Liu X; Jin EZ; Zhi JX; Li XQ
Mol Med Rep; 2011; 4(3):465-9. PubMed ID: 21468593
[TBL] [Abstract][Full Text] [Related]
7. miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation.
Seok HY; Tatsuguchi M; Callis TE; He A; Pu WT; Wang DZ
J Biol Chem; 2011 Oct; 286(41):35339-35346. PubMed ID: 21868385
[TBL] [Abstract][Full Text] [Related]
8. EGR1 Functions as a Potent Repressor of MEF2 Transcriptional Activity.
Feng Y; Desjardins CA; Cooper O; Kontor A; Nocco SE; Naya FJ
PLoS One; 2015; 10(5):e0127641. PubMed ID: 26011708
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle.
Dionyssiou MG; Nowacki NB; Hashemi S; Zhao J; Kerr A; Tsushima RG; McDermott JC
J Mol Cell Cardiol; 2013 Jan; 54():35-44. PubMed ID: 23137781
[TBL] [Abstract][Full Text] [Related]
10. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
[TBL] [Abstract][Full Text] [Related]
11. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression.
Pagiatakis C; Gordon JW; Ehyai S; McDermott JC
J Biol Chem; 2012 Mar; 287(11):8361-70. PubMed ID: 22275376
[TBL] [Abstract][Full Text] [Related]
12. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.
Aude-Garcia C; Collin-Faure V; Bausinger H; Hanau D; Rabilloud T; Lemercier C
Biochem J; 2010 Sep; 430(2):237-44. PubMed ID: 20590529
[TBL] [Abstract][Full Text] [Related]
13. Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling.
Wales S; Hashemi S; Blais A; McDermott JC
Nucleic Acids Res; 2014 Oct; 42(18):11349-62. PubMed ID: 25217591
[TBL] [Abstract][Full Text] [Related]
14. SUMO-1 modification of MEF2A regulates its transcriptional activity.
Riquelme C; Barthel KK; Liu X
J Cell Mol Med; 2006; 10(1):132-44. PubMed ID: 16563226
[TBL] [Abstract][Full Text] [Related]
15. MEF2A regulates the Gtl2-Dio3 microRNA mega-cluster to modulate WNT signaling in skeletal muscle regeneration.
Snyder CM; Rice AL; Estrella NL; Held A; Kandarian SC; Naya FJ
Development; 2013 Jan; 140(1):31-42. PubMed ID: 23154418
[TBL] [Abstract][Full Text] [Related]
16. Evidence for skeletal muscle fiber type-specific expressions of mechanosensors.
Mathes S; Vanmunster M; Bloch W; Suhr F
Cell Mol Life Sci; 2019 Aug; 76(15):2987-3004. PubMed ID: 30701284
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart.
Medrano JL; Naya FJ
J Biol Chem; 2017 Dec; 292(51):20975-20988. PubMed ID: 29054930
[TBL] [Abstract][Full Text] [Related]
18. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7.
Chakraborty S; Reineke EL; Lam M; Li X; Liu Y; Gao C; Khurana S; Kao HY
J Biol Chem; 2006 Nov; 281(46):35070-80. PubMed ID: 16980305
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc.
Kumar A; Hoffman TA; Dericco J; Naqvi A; Jain MK; Irani K
FASEB J; 2009 Dec; 23(12):4344-52. PubMed ID: 19696221
[TBL] [Abstract][Full Text] [Related]
20. Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits.
Ramachandran B; Yu G; Gulick T
J Biol Chem; 2008 May; 283(18):11935-46. PubMed ID: 18222924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
